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ABSTRACT
Introduction: The preterm born infant’s ability to regulate its cerebral blood flow (CBF) is crucial in
preventing secondary ischemic and hemorrhagic damage in the developing brain. The relationship
between arterial blood pressure (ABP) and CBF estimates, such as regional cerebral oxygenation as
measured by near-infrared spectroscopy (NIRS), is an attractive option for continuous non-invasive
assessment of cerebrovascular autoregulation.
Areas covered: The authors performed a literature search to provide an overview of the current
literature on various current clinical practices and methods to measure cerebrovascular autoregulation
in the preterm infant by NIRS. The authors focused on various aspects: Characteristics of patient cohorts,
surrogate measures for cerebral perfusion pressure, NIRS devices and their accompanying parameters,
definitions for impaired cerebrovascular autoregulation, methods of measurements and clinical
implications.
Expert commentary: Autoregulation research in preterm infants has reported many methods for
measuring autoregulation using different mathematical models, signal processing and data require-
ments. At present, it remains unclear which NIRS signals and algorithms should be used that result in
the most accurate and clinically relevant assessment of cerebrovascular autoregulation. Future studies
should focus on optimizing strategies for cerebrovascular autoregulation assessment in preterm infants
in order to develop autoregulation-based cerebral perfusion treatment strategies.
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1. Introduction
More than 10% of all infants worldwide are born preterm,
before 37 completed weeks of gestation [1]. These infants
are at risk for neurodevelopmental sequelae later in life
because of cerebral damage. The pathophysiological mechan-
ism is likely multifactorial and may start before birth and
continue for months after birth. During the first days after
preterm birth, there are strong indications that cerebral ische-
mia, due to hypoxia or fluctuations in cerebral blood flow
(CBF), might play a major role in brain injury and the devel-
opment of motor, cognitive, and behavioral impairment in a
significant proportion of these infants in later childhood [2].
The healthy mature brain has its own protective mechanism in
which CBF is kept constant while cerebral perfusion pressure (CPP)
varies, due to slow adaptations in arteriolar vasoconstriction and
dilatation. This is known as cerebrovascular autoregulation. The
preterm brain is particularly vulnerable to low CBF state leading to
silent ischemic events and the radiological diagnosis of
periventricular leukomalacia (PVL) [3]. On the other hand,
increased CBFmay result in hyperperfusion and subsequent germ-
inal matrix or intraventricular hemorrhage (GMH/IVH) [4]. One of
the suggested factors for the perfusion-related brain injury of the
preterm infant is attributed to a lack of robust cerebrovascular
autoregulation, vividly described by Haruda [5] in 2001:
The structure of normal adult arteries resembles automobile tires,
tough and elastic. In contrast, the vessels of the germinal matrix of
prematures resembles an inner tube, with no surrounding rubber tread
or steel cord, (. . .) disasters waiting to happen. (. . .) This is why exquisite
blood pressure control in the neonatal intensive care is crucial, and
without autoregulation, is like walking a tightrope in a hurricane.
This quote was a response to the article by Tsuji et al. to
underline the importance of realizing and recognizing the
absence of cerebrovascular autoregulation in preterm infants [6].
Haruda hypothesized that the histological nature of the arteries in
the germinal matrix – lacking smooth muscle cells – is the main
cause for this absent or immature autoregulation.
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In reply, the authors stated that,
this lack of muscularis includes virtually all arterial vessels penetrating
the cerebral parenchyma in the third trimester of human gestation.
This is not likely the whole story, (. . .) there is good evidence that in
some premature infants there is a degree of intact cerebrovascular
autoregulation.(. . .) The use of continuous near-infrared spectroscopic
measurements of the cerebral circulation at least gives us a start by
identifying those infants with the abnormality and therefore with the
highest risk for ischemic and hemorrhagic injury. [5]
The above quote clearly describes the issues of absent or
immature capacity of the premature cerebral arterioles to adapt
to systemic challenges like significant arterial blood pressure (ABP)
fluctuations. They have led to several observational studies inves-
tigating different concepts and clinical factors associated with
impaired cerebrovascular autoregulation in preterm infants. We
will present the current knowledge on cerebrovascular autoregu-
lation in preterm infants below to provide substantial background
information before getting to our review focus, reporting the
results of our main literature search on cerebrovascular autoregu-
lation assessment using near-infrared spectroscopy (NIRS) in pre-
term-born infants, in text and in Table 1.
2. Cerebrovascular autoregulation
2.1. Concepts of static and dynamic autoregulation
Cerebrovascular resistance is regulated through changing
the vascular tone of the cerebral arterioles, yielding vasodi-
lation in case of low CPP and vasoconstriction in case of
high CPP [4]. The regulation of vascular resistance is
believed to have individual upper and lower thresholds [7].
The exact thresholds for the upper and lower limit of cere-
brovascular autoregulation have not been identified, partly
due to the fact that most clinical studies rely on sponta-
neous ABP fluctuations which may or may not be within the
CPP range in which autoregulation is functional. Also, these
thresholds might differ between and within infants and
possibly depend on multiple factors, such as gestational
and postnatal age. In neonates, intracranial pressure (ICP)
cannot be measured directly like in adults. Because of the
open fontanel, it is assumed that ICP is low, close to atmo-
spheric pressure. Therefore, ABP is often used as the surro-
gate for CPP. The theoretical background is explained in
Figure 1. It shows the relationship between CBF and ABP
in preterm infants for impaired and intact autoregulation.
This concept is largely adapted from insights from adult
studies [8]; CBF is suggested to be stable (plateau) over a
wide ABP range, reflecting ‘intact’ static cerebrovascular
autoregulation (lower panel in Figure 1). Noteworthy, in
adult studies, it has been suggested that this plateau
might not be completely horizontal [9,10]. Absent autoregu-
lation is often represented by a strong linear relationship
between CBF and ABP (upper panel in Figure 1).
Beyond the thresholds, a status of ‘pressure passivity’
occurs with CBF following changes in CPP directly.
Theoretically, this could lead to either relative cerebral hypo-
perfusion (ischemia) or hyperperfusion (edema or
hemorrhage).
Cerebrovascular autoregulation can be described in two
dimensions which the literature terms ‘static’ and ‘dynamic’
pressure autoregulation. Static autoregulation refers to adap-
tations of the cerebrovascular resistance in a steady-state and
controlled situation, which means an evaluation of CBF at
several steady ABP levels. Experience was initially gained by
data from animal models like preterm lambs [11,12]. Early
techniques that were used to study static autoregulation in
preterm infants are the xenon clearance (133Xe) technique or
the oxyhemoglobin (HbO2) method by NIRS [13–15].
The dynamic autoregulation concept refers to the evalua-
tion of the faster cerebrovascular responses after spontaneous
and relatively brief changes in ABP [16]. Traditionally, transcra-
nial Doppler (TCD) ultrasound is used to measure cerebral
blood flow velocity (CBFV) continuously at the bedside to
determine dynamic autoregulation [17,18]. Limitations of this
noninvasive technique are the assumption of a constant intra-
cerebral vessel caliber, not taking into account the angle of
vessel insonation and difficulties with obtaining long and
stable recordings.
Another noninvasive way for continuous CBF assessment is
measuring the regional cerebral oxygen saturation by NIRS.
The NIRS technology is especially suitable for preterm infants
with thin skulls. Using NIRS for the assessment of cerebrovas-
cular autoregulation will be addressed in depth in this review.
Notably, changes in the cerebral vessel tone and resistance are
influenced by many more factors than ABP alone. Many physiolo-
gical and biochemical mechanisms may interact and affect this
complex mechanism. Accordingly, autoregulation results should
be reviewed with changes in pH, PaCO2, PaO2, metabolism, blood
glucose, sympathetic activation, and effects of neurovascular cou-
pling [4,15,19,20] taken into account. We refer to other reviews for
more in-depth information on these important confounders
affecting cerebral vasoreactivity [4,7,21–23].
3. Cerebrovascular autoregulation in preterm
infants
First reports on impaired cerebrovascular autoregulation in pre-
term infants dated from 1979 to 1980. Lou et al. reported on 19
infants with respiratory distress syndrome (RDS) in combination
with perinatal asphyxia showing a linear relationship between CBF
(measured by the 133Xe technique) and systolic ABPwithin the first
hours after birth [24].Milliganet al. reportedon fivepreterm infants
with increasing CBF values (measured by jugular venous occlusion
plethysmography) after receiving either whole blood or blood
product transfusions resulting in increased mean arterial blood
pressure (MABP) levels of 5–14 mmHg on days 1 till 4 after birth.
All infants developed subsequent intracranial hemorrhages [25].
3.1. Autoregulatory capacity
There is an ongoing debate on whether cerebrovascular auto-
regulation is present in preterm infants at birth or whether it
slowly develops postnatally. Conclusions are limited by the
fact that cerebrovascular autoregulation can also be impaired
due to illness or therapeutic interventions. Two studies found
intact cerebrovascular autoregulation in all of the preterm
infants studied, either undergoing high-frequency oscillatory
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ventilation [26] or treated for hypotension [27]. This was based
on the absent relationship between CBF or cerebral fractional
oxygen extraction (measured by NIRS) and ABP. In contrast,
Boylan et al. studied dynamic autoregulation by measuring
CBFV and ABP and found it to be totally absent in both ‘high-
risk’ (defined as having cerebral pathology, e.g. seizures or
IVH) and control preterm infants [28]. Soul et al. found
impaired cerebrovascular autoregulation in about 20% of the
recording time using NIRS in 87 out of 90 very preterm infants
during the first 5 days after birth [29]. Other studies also
reported on fluctuating autoregulation impairment during
the first days after birth [6,30–33].
3.2. Clinical factors
Clinical factors related to impaired cerebrovascular autoregulation
are lower gestational age (GA) [29,34,35], lower birth weight (BW),
lower glucose levels [29,34,36], higher clinical risk index for babies
(CRIB) score [34], increased infant mortality [34,37], and higher
PaCO2 levels [15,38,39]. Perinatal risk factors such as pregnancy
induced hypertension; antepartum hemorrhage and placental
infarction are also associated with impaired cerebrovascular auto-
regulation [29]. Other pathologies associated with impaired auto-
regulation include RDS [33] and necrotizing enterocolitis [40].
Infants who underwent surgical ligation of patent ductus arterio-
sus (PDA) were found to have more impaired autoregulation
during the first 6 h after surgery compared to those with PDA
treated conservatively withmedication [32]. Associations between
the development of cerebral pathology and impairment of cere-
brovascular autoregulation have been reported. Tsuji et al. and
O’Leary et al. reported that dynamic autoregulation impairment
was associated with an increased risk of developing GMH/IVH or
PVL [6,41]. Alderliesten et al. found a statistically significant corre-
lation between regional cerebral oxygen saturation (rSO2) and
ABP, suggestive of impaired autoregulation, before the develop-
ment of mild-to-moderate IVH. The high correlations maintained
after the development of severe IVH [42]. It is unknown whether
these findings are the direct result of the pathologies or related to
perioperative conditions and medications (e.g. vasopressors and
anesthetics). Finally, being born after intrauterine growth restric-
tion seems to affect cerebral circulation, possibly through addi-
tional autoregulatory mechanisms, that results in redistribution of
blood in favor of the brain and at the expense of organs such as
the kidneys or intestines [43–45].
3.3. Autoregulation thresholds
Even though several studies have studied cerebrovascular
autoregulation and hypotension, static upper and lower
thresholds of ABP for impaired autoregulation in preterm
infants are largely unknown (see also Figure 1). Munro et al.
reported that the lower threshold in MABP for cerebrovascular
autoregulation, measured by NIRS, might be at 29 mmHg for
preterm infants with a GA ranging from 23 to 30 weeks [46].
Other studies were not able to define a clear lower threshold
for their cohorts but used a large change in magnitude or
percentage of time of impaired cerebrovascular autoregula-
tion to define dangerous MABP levels [29,30]. In contrast,
Binder et al. found that a 1-h hypotensive episode (defined
as an MABP below the infant’s GA) did not affect NIRS rSO2
significantly in preterm infants with a GA <37 weeks [47].
4. NIRS in preterm infants
4.1. Technique
Since the turn of the millennium, NIRS has been introduced for
bedside cerebrovascular autoregulation assessment [6]. This
technology is based on the fact that biological tissues are
relatively transparent to near-infrared (600–900 nm wave-
length) light. By shining a near-infrared light through the thin
skin and skull of a preterm-born infant, the amount of oxyge-
nated (HbO2) and deoxygenated hemoglobin (HHb) can be
assessed from the reflected light detected by sensors. From
previous studies, it was estimated that the depth of the signal
is at least between 15 and 20 mm, enough to reach into the
cerebral white matter of these infants [48,49]. Using NIRS,
regional HbO2, HHb, total Hb (HbT = HbO2 + HHb), and differ-
ence Hb (HbD = HbO2 − HHb) in the underlying cerebral tissue
can be measured. Spatially resolved techniques or the multi-
distance approach allows for calculating the ratio of HbO2 to
HbT, expressed by the various manufacturers as the tissue
oxygenation index (TOI, %) [50] or the regional oxygen satura-
tion (rSO2, %), respectively [51]. Assuming a relative constant
cerebral metabolism and therefore oxygen consumption as
well as a stable venous and capillary blood volume, it is thought
that trends in rSO2 or TOI reflect trends in regional CBF [52].
4.2. Limitations
NIRS can be used bedside, continuously and noninvasively, by
placing a sensor on the infant’s forehead. Data are shown real
time and can be stored off-line for analysis. However, the NIRS
technique also has its limitations. It measures only part of the
forebrain, where it measures tissue oxygen saturation which
represents a weighted average of arterial, capillary, and
venous blood. Lacking a gold standard for tissue oxygenation
in preterm infants, these tissue-based values have only been
validated comparing them to venous saturations, mostly in
older children and adults. Though relatively accurate, repeat-
ability of NIRS oximetry, especially after replacement of the
sensor, is rather limited with changes up to 8%. This lack in
precision hampers clinical decision-making [53]. It is unclear
how this affects measurements of cerebrovascular autoregula-
tion using NIRS. One also has to keep in mind that cerebral
oxygenation is both GA and postnatal age dependent. In a
study in 100 relatively healthy infants, born after a GA
between 30 weeks and term age, a GA-dependent cerebral
oxygenation in the first 6-h after birth was observed, with
higher rSO2 in the younger group [54]. On the other hand,
average rScO2 increased with GA (1% per week) in 999 very
preterm infants (<32 weeks), the first 72 h of life [55]. How this
relates to measures of cerebrovascular autoregulation remains
unclear as well. More details regarding the NIRS technique and
its properties and limitations have been described previously
in more detail [53].
EXPERT REVIEW OF NEUROTHERAPEUTICS 803
4.3. Cerebrovascular autoregulation and NIRS
Theoretically, a negative relationship between the input signal
(represented by CPP or ABP) and fluctuations in the output
signal (NIRS parameters) suggests an active or intact cerebro-
vascular autoregulation. However, there is a lack in consensus
on the exact definition or thresholds for impaired cerebrovas-
cular autoregulation and in which conditions NIRS can be used
to represent changes in regional CBF. Furthermore, different
types of methods and mathematical approaches, measuring
times, frequency bands, and outcome measures are used to
describe or validate the autoregulation status.
4.4. Review focus
After this extensive background regarding cerebrovascular
autoregulation in preterm infants, we will now focus on the
most common methods of cerebrovascular autoregulation
assessment using bedside NIRS-derived signals in preterm-
born infants.
5. Review methods
To include all relevant original research articles for this review,
we performed a PUBMED/EMBASE database search using the
search terms ‘(((premature infant[MeSH]) AND cerebrovascular
autoregulation) OR ((premature infant[MeSH]) AND cerebral
autoregulation) OR ((premature infant[MeSH]) AND near infra-
red spectroscopy AND reactivity))). Further inclusion criteria
for the retrieved articles were ‘written in English’ and ‘pub-
lished from 01-01-2000 onwards.’ We checked for relevance by
assessing the title and the abstract. There were 94 hits of
which we selected 22 articles based on following criteria:
being a clinical research article, studying/measuring cerebro-
vascular autoregulation by NIRS, performed in a clinical set-
ting, and studying preterm infants. Furthermore, we added
three relevant articles from screening the references of the
22 retrieved articles, based on the same criteria as stated
above, and focusing on the (mathematical) methodology.
This resulted in 25 articles altogether, of which the details
are summarized in Table 1.
6. Results
The results of the literature search are displayed in Table 1.
Table columns correspond with the following six paragraphs.
6.1. Characteristics of patient cohorts
6.1.1. Timing
Tsuji et al. were the first to show that NIRS can be used to
identify preterm infants with impaired cerebrovascular
Figure 1. Relationship between TCD blood flow velocity and mean ABP in neonates. Upper panel: completely impaired autoregulation. Lower panel: intact
autoregulation is suggested above the (lower) ABP threshold of 36 mmHg. From the material previously presented by Rhee et al J Perinat 2014; 34; 926–931.
Abbreviations: ABP; arterial blood pressure, FV; flow velocity.
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autoregulation at the bedside in 32 preterm infants less than
2 weeks of postnatal age [6]. They found higher coherence
between MABP and NIRS-derived cerebral tissue levels of HbD
in those infants that developed severe IVH or PVL. In the
following years, others performed similar studies, mostly in
the very preterm infants born before 32 weeks of gestation.
Population size varied between 5 and 90 infants. Most mea-
surements were done during the first 3 days of life, some up to
4 weeks after birth (Table 1).
6.1.2. Selection Bias
Using (M)ABP as the input parameter for autoregulation
requires the presence of an indwelling arterial catheter.
Inserting an arterial catheter for the purpose of studying
autoregulation in this very small and vulnerable population
is deemed unethical, and therefore, only infants with arterial
catheters inserted for clinical reasons were included in these
studies. This probably gives a selection bias of the sickest
infants. On the other hand, the infants too small or technically
challenging for insertion of an arterial catheter might have
been excluded from the studies.
6.1.3. Clinical information
Most authors present baseline characteristics of the infants
included, such as being artificially ventilated or not. Others
focus on the techniques and hardly give any information on
the infants included, which may hamper interpretation of data
presented. Out of the 25 articles studied, 14 mention PaCO2 as
a possible confounder, of which 3 actually measured PaCO2
and assessed the relationship between PaCO2 and outcome
[34,41,42] and 2 assessed the influence of PaCO2 on cerebro-
vascular autoregulatory measures [29,56]. None found any
relation between PaCO2, outcome, and autoregulation status.
6.2. Cerebral perfusion pressure: ABP or HR?
6.2.1. Cerebral perfusion pressure
Until 2014, all studies used MABP as the input parameter for
autoregulation calculations using NIRS. As ICP monitoring is
not a standard of care in preterm infants, ABP is only available
as the driving pressure for these calculations. The influence of
ICP in adults, e.g. those with traumatic brain injury, is likely to
significantly affect the CPP, while in preterm infants, it is
fluctuations in the transitional circulation and systemic blood
pressure which probably have a bigger effect on cerebral
perfusion.
6.2.2. Shunting
Limitations of ABPmeasurements in preterm infants are the fact
that ABP deriving from the ascending aorta may differ from the
measured MABP due to shunting of blood typically for the
preterm infants to and from the pulmonary artery over the
ductus arteriosus, which branches just after the aortic arch.
The influence of this shunt on MABP may be important as the
fall in ABP from a large duct is due to the diastolic steel, while
the systolic pressure is usually the same. Furthermore, blood
flow towards the brain may be influenced by other factors that
increase CBF at the expense of blood flow to the less vital
organs for so-called ‘brain-sparing’ mechanism. This is
especially important in intrauterine growth-restricted infants.
This ‘brain-sparing’ phenomenon may continue after birth [44].
6.2.3. Spontaneous ABP fluctuations
To be able to use ABP for assessment of autoregulation,
spontaneous variations in ABP are mandatory. Wong et al.
studied MABP variability and cerebrovascular autoregulation.
Impaired autoregulation was defined as a high coherence
between fluctuations in MABP and the NIRS-derived TOI.
They found impaired cerebrovascular autoregulation to be
associated with increased MABP variability in most infants,
but impaired autoregulation could also be found with
decreased MABP variability in the sickest preterm infants
[57]. Hahn et al. investigated whether the precision of the
cerebrovascular autoregulation index coherence improved
while adjusting for larger MABP fluctuations [58]. They studied
22 very preterm infants (GA <32 weeks) and adjusted for
variability in ABP within and between the repeated measure-
ments. They found that the within measurements, repeatabil-
ity or precision of the autoregulation calculations improved
while adjusting for the magnitude of ABP fluctuations.
6.2.4. Heart rate
A new approach to the assessment of cerebrovascular autore-
gulation in preterm infants was presented byMitra et al. Instead
of ABP, the heart rate (HR), derived from noninvasive ECG
monitoring, was chosen as the input variable for the cerebro-
vascular reactivity challenge [59]. The tissue oxygenation HR
reactivity index (TOHRx) was introduced and calculated in a
similar manner to previously described autoregulatory indices
such as the TCD-derived mean flow velocity index (Mx) and
NIRS-derived TOx (cerebral oximetry index [Cox]) (Figure 2).
TOHRx correlated significantly with the CRIB-II score in 31 pre-
term infants (GA <32 weeks), whereas the other indices did not.
A trend in association betweenmortality and TOHRx was found.
A trend for higher TOHRx values was seen in preterm infants
who received inotropic treatment, had a hemodynamically sig-
nificant PDA, or developed major IVH (grade 3–4) [59].
6.3. NIRS devices and their accompanying parameters
Before NIRS-based cerebral oximetry measurements of TOI/
rSO2 were developed, NIRS parameters used for the assess-
ment of CBF changes were measurements of changes in cere-
bral HbT, HbO2, and HbD levels. These parameters are
sensitive to movement artifacts, which potentially limits their
applicability in both research and clinical settings. This is less
an issue for the NIRS parameters TOI or rSO2, representing
regional oxygenation as a relative measure of the percentage
of the local oxygenated Hb in total Hb using published [61] or
non-disclosed (manufacturer) calculation algorithms.
Nevertheless, De Smet et al. showed in 2009 no difference
between the use of HbD or TOI for autoregulation assessment
[62]. Also, Caicedo et al. showed no relevant differences using
HbD or HbT versus TOI or rSO2 in the resulting correlation or
coherence values, concluding that TOI or rSO2 can also be
used to study cerebrovascular autoregulation in preterm-
born newborns [63]. TOI and rSO2 parameters are most often
used nowadays for autoregulation measurements.
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6.4. Definitions for impaired cerebrovascular
autoregulation
Impaired cerebrovascular autoregulation is defined by a CPP-
dependent CBF [8]. This relationship may be assessed in the
time (correlation analysis) or frequency domain (transfer function
analysis [TFA] with coherence, phase, and gain parameters). As
an example, a higher correlation coefficient or coherence value
between the input (e.g. CPP or MABP) and output parameters
(CBF or TOI or rSO2) might suggest impaired autoregulation.
6.4.1. Thresholds for coherence
Whether sufficient coherence is a prerequisite for reliable
autoregulation calculation using gain and TFA or coherence
has value on its own for assessing autoregulation is still a
matter of debate [64]. Despite this, the coherence variable
itself is frequently used to describe autoregulation status in
preterm infants. Some authors have proposed an absolute
threshold of coherence values for autoregulation impairment,
which ranges in the literature from any value larger than 0 to
coherence values of >0.77 [65]. Coherence >0.5 is the most
frequently chosen threshold based on adult literature [66] or
animal studies [67].
Tsuji et al. supported their choice using a cutoff value of 0.5 on
the fact that more severe cerebral ultrasound abnormalities were
seen in preterm infants with coherence values >0.5 during the first
3 days after birth (47%) compared with preterm infants with
coherence scores <0.5 (13%) [6]. Hahn et al. mathematically calcu-
lated coherence thresholds for variousMABP levels, using complex
mathematical Monte Carlo simulations, resulting in coherence
scores for autoregulation impairment to be >0.47 in the very-
low-frequency range and >0.45 in the low-frequency range [58].
Riera et al. measured superior vena cave (SVC) flow and found that
infants with coherence values between MABP and TOI >0.52 had
lower SVC flow [37]. A possible explanation to this finding may be
that below the lower ABP threshold for autoregulation, a reduced
CBF and subsequently reduced SVC flow occur [68].
6.5. Methods of measurements
Of the 25 articles included in the table, 7 used time-domain
analyses, 9 used frequency-domain analyses, 7 compared the
two, and 2 used other techniques for the assessment of cere-
brovascular autoregulation.
6.5.1. Time-domain analysis
Steiner et al. extended the use of NIRS parameters for dynamic
cerebrovascular autoregulation assessment in adult intensive
care patients at the bedside [69]. They calculated an index of
autoregulation in the time domain using correlation coeffi-
cients between TOI and MABP (TOx), similar to other pressure
reactivity parameters, Mx (using TCD) and pressure reactivity
index (PRx, using ICP) [17]. Using continuous TOI and MABP
monitoring, dynamic autoregulation indices like TOx can be
Figure 2. Recording of two preterm babies which one had permanently good autoregulation (negative TOHRx-mean −0.35; upper panel) and disturbed
autoregulation(mostly positive TOHRX, mean 0.35- lower panel).Red line depicts elusive demarcation between working and disturbed autoregulation (0.25). TOI-
tissue oxygenation index, HR- heart rate, SapO2- arterial saturation, MAP- mean arterial pressure, TOHRx- autoregulation index. X -axis: time scale. Based on clinical
material described by Da Costa et al. [60]. Full color available online.
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calculated continuously with simple moving correlation statis-
tics. A positive TOx value might indicate an MABP-dependent
cerebral oxygenation and CBF. The authors found a high
correlation between the Mx index and TOx index in 23 adult
patients with sepsis or septic shock, suggesting that both
techniques probably contain comparable information about
autoregulation [69].
In 2011, Gilmore et al. introduced the term COx in a pre-
term population, which is essentially the same as the TOx
index, but using rSO2 as a measure of cerebral oxygenation
[30]. A cutoff value of 0.5 was used to delineate intact from
impaired states of cerebrovascular autoregulation in 23 pre-
term infants (GA <30 weeks) with invasive MABP monitoring.
Subsequently, COx values were grouped and averaged accord-
ing to the average MABP in 5 mmHg bins, in order to deline-
ate a range of MABP that is associated with intact
cerebrovascular autoregulation (COx value near 0) or impaired
cerebrovascular autoregulation (COx value near 1). Indeed,
increased COx values occurred at lower MABP values, and
lower MABP values were associated with longer periods of
impaired cerebrovascular autoregulation (COx values >0.5).
Preterm infants born with a lower GA had lower MABP values
but unexpectedly did not show an increased duration with
impaired cerebrovascular autoregulation [30]. Thirteen studies
have used the TOx or COx technique for cerebrovascular
autoregulation assessment in preterm infants (Table 1).
Measurement length varied between 5 and 30 min, and in
case of application of moving calculation windows, the over-
lap was most often set at 50–75%.
Some groups have used single correlations between low-
frequency sampled MABP data (e.g. data averaged every hour)
over longer measurement periods (i.e. 24 h) for cerebrovascu-
lar autoregulation assessment in preterm infants [40,42,56].
This is probably a rather rough method that may both over-
estimate and underestimate the infant’s ability to adapt its
arterioles to changes in ABP. It does not take variation of this
cerebrovascular autoregulation ability in individual infants
within the period measured into account. Nevertheless, in
situations where there is a lack of sufficient data-points, or
the technical ability to assess moving window coherence and
transfer function, this method may roughly indicate the overall
autoregulatory capacity of infants over a certain period of
time.
6.5.2. Frequency-domain analysis
In total, 16 studies used frequency-domain analyses to study
autoregulation in preterm infants (Table 1). Wong et al.
assessed dynamic cerebrovascular autoregulation in the fre-
quency domain, in 24 very preterm infants (GA <32 weeks).
They employed a moving window of frequency-specific MABP
and TOI measurements using TFA [34] (Figure 3). They com-
puted ‘power spectral densities’ from the frequency-domain
data, which were used to generate the TFA variables coher-
ence and gain from the two signals. High coherence and
increased gain values are interpreted as impaired dynamic
autoregulation [16]. The authors state that the coherence
function characterizes the frequency-dependent linear relation
between MABP and TOI which is a prerequisite for reliable
calculation of the gain using TFA. The gain represents the
magnitude (or dampening effect) of changes in TOI (output
signal) resulting from the change in MABP (input signal) at
specific frequencies. Hahn et al. validated the use of the TFA
variables coherence and gain from the two parameters TOI
and MABP to assess cerebrovascular autoregulation in a piglet
model [70]. For a detailed overview regarding the TFA analysis,
we refer to the recent paper by Claassen et al. [71].
6.5.3. Frequency ranges for autoregulation calculation
The current pressure autoregulation concept is built on the
fact that slow and prolonged periods of hypotension or hyper-
tension are likely more injurious than fast and transient (beat
to beat) changes in ABP. This concept is often referred to as
the ‘high-pass filter’ principle of autoregulation [16]. Especially,
the low- and the very-low-frequency ranges are considered
physiologically most important for cerebrovascular autoregu-
lation, since in these frequencies most adaptations of cerebral
perfusion to slow ABP fluctuations are seen. However, in the
very-low-frequency range, contributions of other physiological
variables (like PaCO2 and sympathetic influence) take place,
making interpretation of cerebrovascular autoregulation
results more complex [72]. TFA values can be calculated in
different frequency ranges: 0.005–0.02 Hz (sub-very low fre-
quency), 0.02–0.07 Hz (very low frequency), 0.07–0.15 Hz (low
frequency), and 0.15–0.40 Hz (high frequency) [73], although
various authors use various definitions for the various ranges.
Tsuji et al. found a higher coherence score in the very-low-
frequency range for preterm infants with severe cerebral ultra-
sound abnormalities (grade 3–4 GMH-IVH or PVL) compared to
infants with normal or minimal abnormal ultrasound findings
[6]. Also, Wong et al. showed highest coherence and gain in
the very-low-frequency range (0.003–0.02 Hz) [34].
6.5.4. Time-domain versus frequency-domain analysis
Caicedo et al. compared various approaches for cerebrovascular
autoregulation assessment. Based on measurements in 18 pre-
term infants, they calculated the time-domain Pearson correlation
coefficient (COx) and the frequency-domain TFA (modified) coher-
ence, gain, and phase [74]. The variable phase describes the phase
shift or delay between the input and output signals. Higher gains
and low-phase values probably represent impaired autoregula-
tion. In addition, they investigated whether mathematical para-
meters used in the TFA such as measurement lengths (epoch
length) and overlapping percentages influenced the final results.
Maximal sensitivity for the assessment of autoregulation and
power for the various approaches was reached at approximately
60% time-window overlap and using measurement length
between 14 and 22 min. The authors found that the TFA gain
and the Pearson correlation were the most robust methods to
detect changes in the parameters compared to other methods
such as TFA phase and coherence. However, correlation ignores
any delays in the signals under analysis, while TFA can assess
causal relationship between MABP and CBF [74]. Morren et al.
suggested that because time-domain correlation showed a higher
concordance between HbD and MABP in several preterm infants
(number not specified) than TFA coherence did in those infants,
the correlation index might be a more sensitive measure for
impaired autoregulation than coherence [75].
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Eriksen et al. also compared the time- versus frequency-
domain methods for describing cerebrovascular autoregula-
tion. In the frequency-domain analysis, they used the variables
coherence and gain, and for the time-domain analysis, they
used COx in 60 very preterm infants (GA 26.6 ± 1.3 weeks).
They found that the concordance between the two methods
was poor: the two methods did not classify the same infants as
having intact or impaired cerebrovascular autoregulation [76].
De Smet et al. suggested that the partial coherence (PCOH)
method might be more accurate in predicting brain damage
and more sensitive for detecting impaired autoregulation [77].
PCOH allows for the elimination of the linear influence of one
signal on another and can therefore be applied in periods of
fluctuating peripheral arterial saturation (SaO2). In a cohort of
30 preterm infants, using PCOH, they found longer periods of
time and more patients with pressure-passive NIRS values,
independent of SaO2, than using the simple coherence value.
Comparing all these studies do not reveal any clear benefit of
any of the mathematical approaches, and the different methods
provide different results on the autoregulatory capacity of
preterm infants. Without a gold standard for measuring cerebro-
vascular autoregulation, it may be impossible to prove any of the
methods optimal. In addition, the heterogeneous mathematical
approaches and outcome measurements hamper comparison
between neonatal studies on autoregulatory capacity.
6.5.5. Other autoregulation models
Riera et al. proposed that the assumed synchronized changes in
the input and output parameters representing CPP and CBF such
as those described above undermine any other possible time
relationship between the two. They therefore introduced a new
prediction model, the bivariate autoregressive spectral coher-
ence (BiAR-COH) method, to predict cerebral oxygenation
changes in relationship to MABP changes from previous samples
in the very-low-frequency range. They showed that this model
was superior to the simple TFA coherence method for predicting
low SVC flow or adverse outcome in 54 preterm infants [37].
Bauer et al. suggested a methodological solution for the
fact that many input oscillations are quasiperiodic, nonstation-
ary, and noisy [60]. They propose a phase-rectified signal
averaging (PRSA) method, which uses anchor points in the
input signal which are used to align the oscillatory systolic ABP
fluctuations, followed by a signal averaging. Benefit of PRSA
over conventional frequency analysis and correlation analysis
is the fact that in noisy or quasiperiodic signals, phase changes
may lead to over- or underdetection of correspondence
between signals. Using PRSA, anchor points are determined
from the input signal itself, searching for phase-synchronized
signals. Caicedo et al. also reported on the clinical capacity of
(bivariate) PRSA to differentiate between five preterm infants
with high-grade IVH versus four control infants with normal
cranial ultrasound findings, matched by GA, BW, and sex [78].
They used both ABP (one mean ABP and one systolic ABP) and
HR combined with rSO2 measurements for their analyses. The
results showed the presence of a nonlinear relationship
between ABP and rSO2 for both increasing (input signal
increase) and decreasing (input signal decrease) anchor points.
Especially in the patients with IVH, the time profiles of the
PRSA curves showed impaired autoregulation possibly due to
a difference in maturation compared to control infants with
matched GA. The authors suggest that larger studies are
warranted to validate bivariate PRSA analyses for cerebrovas-
cular autoregulation assessment in preterm infants.
6.6. Clinical implications for autoregulation
measurements
6.6.1. Clinical end points
Many authors have used clinical outcome such as IVH or
mortality to validate their autoregulation measurements,
assuming IVH and mortality to occur more often with impaired
autoregulation (Table 1). These relationships may not be cau-
sal, especially with the lack of a gold standard for assessing
cerebrovascular autoregulation. Noteworthy, not all studies
found a positive relation between impaired autoregulation
and chosen clinical end points [56,79,80], where many others
did [6,29,34,37,41,59,77,78,81–83]. In contrast to all others,
Stammwitz et al. even found a positive relation between low
Figure 3. Example of high TFA for TOI and MAP values in the ultralow frequency
from the Wong et al. study in 2 preterm born infants born at 23 and 25 weeks
gestation, shown respectively in (a) and (b) [34]. The infant in (a) showed
fluctuations of TOI of higher magnitude in response to changes in MAP,
compared with the infant in (b). Accordingly, the value of gain in the ULF
range for the recording in (a) was higher than the value for the recording in (b)
(0.8 vs 0.4%/mm Hg, respectively). Note that both recordings showed concor-
dant changes between MAP and TOI waveforms, with the ULF coherence values
both at 0.6. Reproduced with permission from Pediatrics, Vol. 121, Page(s) e604-
11, Copyright © 2008 by the AAP. Abbreviations: TOI; tissue oxygenation index,
MAP; mean arterial pressure, ULG; ultra-low frequency.
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coherence and IVH development in 31 ventilated preterm
infants with RDS. The authors suggest that within the fre-
quency range they measured (0–0.01 Hz and 0–0.1 Hz) that a
high coherence is a reflection of ‘a high coordination of phy-
siological cycles and an indicator of maturation and integ-
rity’ [84].
For quantifying the time burden of limited autoregulatory
capacity in preterm infants, Soul et al. introduced the term
‘pressure-passive index’ (PPI) [29]. This PPI is defined as the
percentage of 10-min periods with high coherence (>0.77) in
the very-low-frequency range between MABP and NIRS-
derived HbD values. This occurred in the majority of infants
for mean 20% of the time and was significantly associated
with low GA and BW, hypotension, and maternal hemody-
namic factors. In the study by Wong et al., a high coherence
and high gain was found especially in the sickest preterm
infants [34]. Coherence was superior in predicting mortality
to the CRIB score, a highly predictive index of mortality [85,86].
However, in contrary to what Tsuji et al. [6] had previously
found, no association was found between the averaged coher-
ence and ultrasound cerebral abnormalities. This study was
probably underpowered to find such associations [34].
6.6.2. Using the integrity of autoregulation to define
optimal blood pressure
Many preterm infants are probably able to regulate CBF within
certain limits of ABP. An objective measure of ‘optimal’ ABP
could be the strength and objective of assessing cerebrovas-
cular autoregulation or reactivity. This has been extensively
investigated in adult patients [87]. Using TOHRx as an index of
cerebrovascular reactivity in a cohort of 60 preterm infants, da
Costa et al. were able to define ABPopt in 81% of the infants
using a moving 4-h monitoring window (Figure 4). They
showed (Figure 4) that deviation from ABPopt correlated
with IVH (MABP > ABPopt) or with mortality (MABP <
ABPopt) [82]. The ABPopt methodology could provide clini-
cians with a ‘safe’ range of MABP in the individual patient at
any specific time point and then to adjust treatments to keep
MABP within that range; however, the data need to be avail-
able in real time, and this approach would then need formal
prospective testing.
7. Conclusion and future directions
For understanding and improving the long-term neurodevelop-
mental outcome of preterm infants, it might be crucial to be
able to adequately and safely assess the autoregulatory capa-
city and to detect and prevent unnoticed cerebral hypo- or
hyperperfusion and secondary brain injury. NIRS might fulfill
these requirements and can be used to measure regional cere-
bral oxygenation as a surrogate for changes in regional CBF.
Although the methodology has progressed over time,
uncertainties regarding the interpretation of the absolute sig-
nals and autoregulation calculations algorithms remain, limit-
ing its current clinical applications at the moment. Many
different NIRS parameters and cerebrovascular autoregulation
calculations are currently being used for the assessment of
cerebrovascular autoregulation in preterm infants (Table 1).
Also, newly developed techniques that are based on the
NIRS principle such as diffuse correlation spectroscopy
[88,89] may offer novel opportunities for the assessment of
CBF and autoregulation in preterm infants.
As we show in this overview, the variety in methodology
makes understanding and interpretation of the results for
clinicians difficult. At the moment, there is a large variety of
mathematical approaches, measurement lengths, overlap per-
centages, frequency ranges, and signal (pre-)processing. In
studies on preterm infants, most authors have used correlation
indices (time domain) or TFA (frequency domain) to describe
the linear relationship between MABP and NIRS estimates of
CBF. Most studies agree on the fact that these approaches
indeed assess cerebrovascular autoregulation which often is
related to short-term cerebral injury.
In adult research, steps have been taken very recently to
standardize the autoregulation measurements and
Figure 4. Example of determination of ABPopt (in this cases minimum of the U-shape curve suggest ‘optimum’ at ABP = 29 mmHg) using clinical data previously published by
Da Costa et al. [60] (with permission from the authors). Abbreviations: ABP; arterial blood pressure, TOHRx; tissue oxygenation heart rate reactivity index.
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methodology for TCD measurements [71]. Such initiatives
have not been undertaken for NIRS.
For clinical purposes, NIRS-based autoregulation assess-
ment may help in defining the ‘optimal ABP’ or the lower
level of autoregulation for an individual infant, which might
provide important information for clinicians to manage ABP in
a patient-specific manner. However, the need for continuous
ABP measurement implies the presence of an indwelling arter-
ial line, which is not always available in these small preterm
infants. It would therefore be interesting to better understand
the role of HR in cerebrovascular reactivity, as this measure-
ment is universally available in all infants on NICU.
Finding the optimal way to validly assess cerebrovascular
autoregulation in preterm infants in a clinical setting would
allow for clinicians to guide treatment and improve outcome
in this vulnerable population. In our opinion, steps should be
taken towards agreement on uniform methodology with the
aim of using indices of cerebrovascular autoregulation as a
marker to optimize blood pressure management and cerebral
perfusion in preterm infants. This should then be investigated
in large trials with meaningful clinical outcomes.
8. Expert commentary
Management of CPP in preterm-born infants is challenging
due to largely unknown individual targets and maturation
status of cerebrovascular autoregulating vessels. One attrac-
tive option is to estimate ABP targets for providing adequate
CPP and CBF, by assessing the dynamic autoregulatory capa-
city at the bedside continuously and noninvasively. NIRS
might fulfill these requirements and can be used to measure
regional cerebral oxygenation as a surrogate for changes in
regional CBF. Autoregulation research in preterm infants has
reported many methods for measuring autoregulation using
different mathematical models, signal (pre)processing, and
data requirements (frequency bands, measurement length,
and data overlap percentages). Methodological comparative
studies are limited. A gold standard for validation of the
measurement methods is lacking, and different clinical out-
come variables for validation have been used. At present, it
remains unclear which NIRS signals and (manufacturer) algo-
rithms should be used that result in the most accurate and
clinically relevant assessment of cerebrovascular autoregula-
tion. Future studies should focus on optimizing strategies for
cerebrovascular autoregulation assessment in preterm infants
in order to develop autoregulation-based cerebral perfusion
treatment strategies.
9. Five-year view
Prerequisite for incorporating autoregulation measures in clin-
ical decision-making would be to investigate which of the
available NIRS devices, parameters, and algorithms have the
highest and most reliable diagnostic value for regional cere-
bral oxygenation changes. However, the only way to validate
the bedside NIRS measurement is the use of clinical outcome
as a surrogate of abnormal cerebral perfusion, since no gold
standard for measurements of cerebral hypo- or hyperperfu-
sion in human preterm infants exists. Alternatives for invasive
ABP measurements as a surrogate for CPP also need to be
explored. There are several reasons; first, ABP in the preterm
may not represent CPP, and second, not all preterm infants
have indwelling arterial lines for continuous ABP measure-
ments. Thirdly, as fluctuations in the input signal are essential
for challenging the autoregulation system, the use of (nonin-
vasive) HR-based cerebrovascular reactivity deserves further
exploration. Consensus should be reached about the selection
of most relevant clinical outcome variables for comparing the
diagnostic and prognostic value of different NIRS methods.
Standardization of the methodology should be advocated
and published.
The next step would be to design intervention studies on
implementing knowledge on autoregulatory capacity to see if
various clinical interventions indeed improve physiological end
points like cerebral oxygenation and autoregulatory capacity.
Finally, this should lead to the development of phase III studies,
for example, comparing cerebrovascular autoregulation-defined
optimal ABP management with conventional ABP management,
with important clinical end points such as long-term neurological
outcome.
Key issues
● Cerebrovascular autoregulation is a complex process that is
influenced by many different factors in preterm infants. The
level of maturity and function of the preterm cerebral
arterioles remain a matter of debate.
● There is a promising role for cerebrovascular autoregulation
measurement using NIRS in preterm infants due to its non-
invasive, cheap, safe and continuous signals.
● Cerebrovascular autoregulation in preterm infants has been
quantified in various ways, using different input and output
parameters, and various mathematical approaches, without
clear standardization or validation.
● Most authors have used correlations (time domain) or trans-
fer function (frequency domain) analysis to describe the
relationship between ABP and NIRS. There is no agreement
regarding measurement length, data overlap percentage,
which frequency bands contain the most relevant informa-
tion and how to combine NIRS with other brain monitoring
signals.
● Since the heart rate (HR) signal shows more slow sponta-
neous fluctuations compared to the ABP signal in preterm
infants, and can be assesses non-invasively, the use of HR
based cerebrovascular reactivity indices deserve further
exploration.
● In this review we provide an overview of the different NIRS
methodologies used for assessing preterm cerebrovascular
autoregulation, and their (mostly observational) data collec-
tion and interpretation. At present the large diversity and
heterogeneity of the NIRS studies limits conclusions about
the (possible) clinical benefit of autoregulation monitoring
with NIRS.
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